CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
drug LY3484356 alone or in combination with other anticancer therapies is safe and effective in participants with advanced or metastatic breast cancer...
Phase 1
Rochester, Minnesota, United States and 75 other locations
This study, ELU- FRα-1, is focused on adult subjects who have advanced, recurrent or refractory folate receptor alpha (FRα) overexpressing tumors con...
Phase 1, Phase 2
Rochester, Minnesota, United States and 17 other locations
first-in-human study will evaluate the safety, tolerability, pharmacokinetics, and antitumor activity of TORL-1-23 in patients with advanced cancer...
Phase 1
Rochester, Minnesota, United States and 3 other locations
-small-cell lung cancer (NSCLC), triple negative breast cancer (TNBC), ovarian cancer (OC), endometrial cancer...
Phase 1, Phase 2
Rochester, Minnesota, United States and 123 other locations
can be given alone or with cemiplimab to patients with ovarian cancer or cancer of the uterusThe study will also look at the levels...
Phase 1, Phase 2
Rochester, Minnesota, United States and 46 other locations
A Phase 1B/2A study will be conducted to establish safety and dose level of AMXT 1501 dicaprate in combination with IV DFMO, in cancer patie...
Phase 1, Phase 2
Rochester, Minnesota, United States and 6 other locations
The purpose of the trial is to evaluate the safety of acasunlimab (also known as GEN1046) as monotherapy and in combination therapies in patients wit...
Phase 1, Phase 2
Rochester, Minnesota, United States and 56 other locations
This is a multi-center, open-label, first-in-human Phase 1 study evaluating the anti-programmed death receptor 1 (anti-PD-1) antibody dostarlimab (al...
Phase 1
Rochester, Minnesota, United States and 144 other locations
Clinical trials
Research sites
Resources
Legal